MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 1,535,012 Shares of Core Scientific, Inc. (NASDAQ:CORZ)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 1,204.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,662,406 shares of the company’s stock after buying an additional 1,535,012 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Core Scientific were worth $23,357,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Wealth Enhancement Advisory Services LLC lifted its position in shares of Core Scientific by 25.6% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company’s stock worth $1,378,000 after buying an additional 20,000 shares during the period. JPMorgan Chase & Co. raised its position in Core Scientific by 48.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company’s stock valued at $5,192,000 after purchasing an additional 142,068 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in Core Scientific in the fourth quarter worth $527,000. Stephens Inc. AR acquired a new position in Core Scientific in the fourth quarter worth $927,000. Finally, Exchange Traded Concepts LLC boosted its stake in Core Scientific by 27.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 629,329 shares of the company’s stock worth $8,842,000 after purchasing an additional 136,212 shares in the last quarter.

Core Scientific Stock Up 0.8%

CORZ stock opened at $10.32 on Thursday. The company has a market cap of $3.07 billion, a P/E ratio of -1.91 and a beta of 6.66. Core Scientific, Inc. has a twelve month low of $3.58 and a twelve month high of $18.63. The business has a fifty day moving average of $7.98 and a 200-day moving average of $12.03.

Core Scientific (NASDAQ:CORZ) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.10) EPS for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.02. The company had revenue of $79.53 million during the quarter, compared to the consensus estimate of $92.04 million. The company’s revenue for the quarter was down 55.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.78 EPS. As a group, equities research analysts anticipate that Core Scientific, Inc. will post 0.52 earnings per share for the current fiscal year.

Insider Activity at Core Scientific

In other Core Scientific news, Director Jordan Levy bought 62,500 shares of the firm’s stock in a transaction on Thursday, March 6th. The stock was purchased at an average cost of $8.01 per share, with a total value of $500,625.00. Following the completion of the purchase, the director now owns 306,887 shares in the company, valued at approximately $2,458,164.87. The trade was a 25.57% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Todd A. Becker sold 134,250 shares of Core Scientific stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $10.75, for a total value of $1,443,187.50. Following the transaction, the director now owns 195,687 shares in the company, valued at $2,103,635.25. This trade represents a 40.69% decrease in their position. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

CORZ has been the topic of a number of recent analyst reports. Canaccord Genuity Group reissued a “buy” rating and issued a $17.00 price objective on shares of Core Scientific in a research note on Friday, May 9th. Craig Hallum initiated coverage on Core Scientific in a research note on Tuesday, January 21st. They issued a “buy” rating and a $24.00 price objective on the stock. HC Wainwright reissued a “buy” rating and issued a $17.00 price objective on shares of Core Scientific in a research note on Tuesday, March 11th. Compass Point reduced their price objective on Core Scientific from $26.00 to $20.00 and set a “buy” rating on the stock in a research note on Tuesday, February 25th. Finally, Oppenheimer initiated coverage on Core Scientific in a research note on Wednesday. They issued an “outperform” rating and a $15.00 price objective on the stock. Sixteen equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Core Scientific currently has a consensus rating of “Buy” and an average price target of $18.81.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.